Imatinib - Inhibikase Therapeutics

Drug Profile

Imatinib - Inhibikase Therapeutics

Alternative Names: IkI 001; IkI-001Pro; IkT-001; IKT-001Pro PML; IKT-001Pro PVAN

Latest Information Update: 20 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Inhibikase Therapeutics
  • Class Antineoplastics; Antivirals; Benzamides; Piperazines; Pyridines; Pyrimidines; Small molecules
  • Mechanism of Action Bcr-abl tyrosine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Progressive multifocal leukoencephalopathy
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Human polyomavirus infections; Progressive multifocal leukoencephalopathy

Most Recent Events

  • 13 Aug 2015 Inhibikase Therapeutics plans an observational clinical trial for Progressive multifocal leukoencephalopathy in USA
  • 21 May 2014 Imatinib - Inhibikase Therapeutics receives Orphan Drug status for Progressive multifocal leukoencephalopathy in USA
  • 16 Aug 2011 US FDA grants clearance for a phase II trial of IkT 001 in Polyomavirus infections in patients with Multiple sclerosis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top